|The ATG9A atg9a (Catalog #MBS646615) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The ATG9A, CT (ATG9A, APG9L1, Autophagy-related protein 9A, APG9-like 1, mATG9) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s ATG9A can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB), Immunohistochemistry (IHC).
Suitable for use in Western Blot, Immunohistochemistry, ELISA
Dilution: ELISA: 1:1,000
Western Blot: 1:100-500
Immunohistochemistry: 1:50-100. Researchers should empirically determine the suitability of the ATG9A atg9a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The ATG9A atg9a product has the following accession number(s) (GI #116089287) (NCBI Accession #NP_076990.4) (Uniprot Accession #Q7Z3C6). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Macroautophagy is the major inducible pathway for the general turnover of cytoplasmic constituents in eukaryotic cells, it is also responsible for the degradation of active cytoplasmic enzymes and organelles during nutrient starvation. Macroautophagy involves the formation of double-membrane bound autophagosomes which enclose the cytoplasmic constituent targeted for degradation in a membrane bound structure, which then fuse with the lysosome (or vacuole) releasing a single-membrane bound autophagic bodies which are then degraded within the lysosome (or vacuole). Apg9 plays a direct role in the formation of the cytoplasm to vacuole targeting and autophagic vesicles, possibly serving as a marker for a specialized compartment essential for these vesicle-mediated alternative targeting pathways.
Immunogen: ATG9A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 724~754 amino acids from the C-term of human APG9L1. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing ATG9A are readily searchable from our website. Different antibodies against the same target such as ATG9A may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Death are some of the diseases may be linked to ATG9A, CT (ATG9A, APG9L1, Autophagy-related protein 9A, APG9-like 1, mATG9). Brain, Heart, Kidney tissues are correlated with this protein.